Common TitleOPTIMIST-1
Official Title Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study
Phase Phase III
ClinicalTrials.gov NCT02114177
Treatments
Sofosbuvir
, Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedSimeprevir
Simeprevir
Tradename:OlysioOther Names:SMVClass:DiscontinuedFunding
IndustryJanssen